CD8+CD28–CD57+ T cells from peripheral blood have been shown to play an active pro-tumor role via suppressing proliferation of responder T cells [34], and removal of these cells in vitro restored T cell proliferative capacity [50, 51]. Here, CD28 is linked to neoplasm.